FDA says shortage ends for Eli Lilly weight loss and diabetes drug
Oct 03, 2024
The shortage of tirzepatide, used by pharmaceutical giant Eli Lilly in diabetes medication Mounjaro and weight loss drug Zepbound, is officially over, the Food and Drug Administration said Wednesday.
https://www.washingtontimes.com/news/2024/oct/3/fda-says-shortage-ends-for-eli-lilly-weight-loss-a/?utm_source=RSS_Feed&utm_medium=RSS
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service